BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perrone B, La Cognata V, Sprovieri T, Ungaro C, Conforti FL, Andò S, Cavallaro S. Alternative Splicing of ALS Genes: Misregulation and Potential Therapies. Cell Mol Neurobiol 2020;40:1-14. [PMID: 31385134 DOI: 10.1007/s10571-019-00717-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Zakharova M. Modern approaches in gene therapy of motor neuron diseases. Med Res Rev 2021;41:2634-55. [PMID: 32638429 DOI: 10.1002/med.21705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Karagiannis P, Inoue H. ALS, a cellular whodunit on motor neuron degeneration. Mol Cell Neurosci 2020;107:103524. [PMID: 32629110 DOI: 10.1016/j.mcn.2020.103524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yang X, Ji Y, Wang W, Zhang L, Chen Z, Yu M, Shen Y, Ding F, Gu X, Sun H. Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies. Antioxidants (Basel) 2021;10:1012. [PMID: 34202494 DOI: 10.3390/antiox10071012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chatterjee B, Shen CJ, Majumder P. RNA Modifications and RNA Metabolism in Neurological Disease Pathogenesis. Int J Mol Sci 2021;22:11870. [PMID: 34769301 DOI: 10.3390/ijms222111870] [Reference Citation Analysis]
5 Assunto A, Ferrara U, De Luca A, Pivonello C, Lombardo L, Piscitelli A, Tortora C, Pinna V, Daniele P, Pivonello R, Russo MG, Limongelli G, Colao A, Tartaglia M, Strisciuglio P, Melis D. Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1. Orphanet J Rare Dis 2019;14:261. [PMID: 31730495 DOI: 10.1186/s13023-019-1223-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
6 Wu D, Zang YY, Shi YY, Ye C, Cai WM, Tang XH, Zhao L, Liu Y, Gan Z, Chen GQ, Xu Y, Yang JJ, Shi YS. Distant coupling between RNA editing and alternative splicing of the osmosensitive cation channel Tmem63b. J Biol Chem 2020;295:18199-212. [PMID: 33100268 DOI: 10.1074/jbc.RA120.016049] [Reference Citation Analysis]
7 Lejman J, Zieliński G, Gawda P, Lejman M. Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy. Genes (Basel) 2021;12:1346. [PMID: 34573328 DOI: 10.3390/genes12091346] [Reference Citation Analysis]
8 La Cognata V, Gentile G, Aronica E, Cavallaro S. Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain Regions. Cells 2020;9:E159. [PMID: 31936368 DOI: 10.3390/cells9010159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Jakubauskienė E, Kanopka A. Alternative Splicing and Hypoxia Puzzle in Alzheimer's and Parkinson's Diseases. Genes (Basel) 2021;12:1272. [PMID: 34440445 DOI: 10.3390/genes12081272] [Reference Citation Analysis]
10 Chiò A, Mazzini L, Mora G. Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology 2020;167:107986. [DOI: 10.1016/j.neuropharm.2020.107986] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
11 Li D, McIntosh CS, Mastaglia FL, Wilton SD, Aung-Htut MT. Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies. Transl Neurodegener 2021;10:16. [PMID: 34016162 DOI: 10.1186/s40035-021-00240-7] [Reference Citation Analysis]